Tan, E. M. & Kunkel, H. G. Traits of a Soluble Nuclear Antigen Precipitating with Sera of Sufferers with Systemic Lupus Erythematosus. J. Immunol. 96, 464–471 (1966).
Abdelal, I. T., Zakaria, M. A., Sharaf, D. M. & Elakad, G. M. Ranges of plasma cell-free DNA and its correlation with illness exercise in rheumatoid arthritis and systemic lupus erythematosus sufferers. Egypt. Rheumatol. 38, 295–300 (2016).
Koike, Y. et al. Dynamic pathology for circulating free DNA in a dextran sodium sulfate colitis mouse mannequin. Pediatr. Surg. Int. 30, 1199–1206 (2014).
Vrablicova, Z. et al. Nuclear and Mitochondrial Circulating Cell-Free DNA Is Elevated in Sufferers With Inflammatory Bowel Illness in Scientific Remission. Entrance. Med. 7, 593316 (2020).
González, L. A., Ugarte-Gil, M. F. & Alarcón, G. S. Systemic lupus erythematosus: The seek for the perfect biomarker. Lupus 30, 181–203 (2021).
Verstockt, B. et al. Outcomes of the Seventh Scientific Workshop of ECCO: Precision Medication in IBD—Illness Final result and Response to Remedy. J. Crohns Colitis 15, 1431–1442 (2021).
Xu, Y. et al. Excessive ranges of circulating cell-free DNA are a biomarker of energetic SLE. Eur. J. Clin. Make investments. 48, e13015 (2018).
Truszewska, A. et al. Cell-free DNA profiling in sufferers with lupus nephritis. Lupus 29, 1759–1772 (2020).
Mondelo-Macía, P., Castro-Santos, P., Castillo-García, A., Muinelo-Romay, L. & Diaz-Peña, R. Circulating Free DNA and Its Rising Position in Autoimmune Illnesses. J. Pers. Med. 11, 151 (2021).
Kubiritova, Z., Radvanszky, J. & Gardlik, R. Cell-Free Nucleic Acids and their Rising Position within the Pathogenesis and Scientific Administration of Inflammatory Bowel Illness. Int. J. Mol. Sci. 20, 3662 (2019).
Duvvuri, B. & Lood, C. Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Illnesses. Entrance. Immunol. 10, 502 (2019).
Bianchi, D. W. & Chiu, R. W. Okay. Sequencing of Circulating Cell-free DNA throughout Being pregnant. N. Engl. J. Med. 379, 464–473 (2018).
Wan, J. C. M. et al. Liquid biopsies come of age: in direction of implementation of circulating tumour DNA. Nat. Rev. Most cancers 17, 223–238 (2017).
Vermeesch, J. R., Voet, T. & Devriendt, Okay. Prenatal and pre-implantation genetic prognosis. Nat. Rev. Genet. 17, 643–656 (2016).
Lo, Y. M. D. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485–487 (1997).
Bayindir, B. et al. Noninvasive prenatal testing utilizing a novel evaluation pipeline to display screen for all autosomal fetal aneuploidies improves being pregnant administration. Eur. J. Hum. Genet. 23, 1286–1293 (2015).
Van Den Bogaert, Okay. et al. Final result of publicly funded nationwide first-tier noninvasive prenatal screening. Genet. Med 23, 1137–1142 (2021).
Lenaerts, L. et al. Complete genome-wide evaluation of routine non-invasive take a look at information permits most cancers prediction: A single-center retrospective evaluation of over 85,000 pregnancies. EClinicalMedicine 35, 100856 (2021).
van der Meij, Okay. R. M. et al. TRIDENT-2: Nationwide Implementation of Genome-Large Non-Invasive Prenatal Testing as a First-Tier Screening Take a look at within the Netherlands. Am. J. Hum. Genet. https://doi.org/10.1016/j.ajhg.2019.10.005 (2019).
Mackie, F., Hemming, Okay., Allen, S., Morris, R. & Kilby, M. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a scientific evaluate and bivariate meta-analysis. BJOG Int. J. Obstet. Gynaecol. 124, 32–46 (2017).
Suzumori, N. et al. Classification of things concerned in nonreportable outcomes of noninvasive prenatal testing (NIPT) and prediction of success price of second NIPT. Prenat. Diagn. 39, 100–106 (2019).
Hui, L. & Bianchi, D. W. Fetal fraction and noninvasive prenatal testing: What clinicians have to know. Prenat. Diagn. 40, 155–163 (2020).
Samura, O. & Okamoto, A. Causes of aberrant non-invasive prenatal testing for aneuploidy: A scientific evaluate. Taiwan. J. Obstet. Gynecol. 59, 16–20 (2020).
MacKinnon, H. J. et al. The impression of maternal autoimmune illness on cell-free DNA take a look at traits. Am. J. Obstet. Gynecol. MFM 3, 100466 (2021).
Haghiac, M. et al. Elevated Loss of life of Adipose Cells, a Path to Launch Cell-Free DNA Into Systemic Circulation of Overweight Ladies. Weight problems 20, 2213–2219 (2012).
Dabi, Y. et al. Autoimmune problems however not heparin are related to cell-free fetal DNA take a look at failure. J. Transl. Med. 16, 335 (2018).
Hui, C. Y. Y., Tan, W. C., Tan, E. L. & Tan, L. Okay. Repeated failed non-invasive prenatal testing in a lady with immune thrombocytopenia and antiphospholipid syndrome: classes learnt. Case Rep. 2016, bcr2016216593 (2016).
Hui, L., Bethune, M., Weeks, A., Kelley, J. & Hayes, L. Repeated failed non-invasive prenatal testing owing to low cell-free fetal DNA fraction and elevated variance in a lady with extreme autoimmune illness. Ultrasound Obstet. Gynecol. 44, 242–243 (2014).
Che, H. et al. Pan-Most cancers Detection and Typing by Mining Patterns in Giant Genome-Large Cell-Free DNA Sequencing Datasets. Clin. Chem. hvac095 https://doi.org/10.1093/clinchem/hvac095 (2022).
Rees, F., Doherty, M., Grainge, M. J., Lanyon, P. & Zhang, W. The worldwide incidence and prevalence of systemic lupus erythematosus: a scientific evaluate of epidemiological research. Rheumatology 56, 1945–1961 (2017).
Rees, F. et al. The incidence and prevalence of systemic lupus erythematosus within the UK, 1999–2012. Ann. Rheum. Dis. 75, 136–141 (2016).
Shand, A., Chen, J., Selby, W., Solomon, M. & Roberts, C. Inflammatory bowel illness in being pregnant: a population-based examine of prevalence and being pregnant outcomes. BJOG Int. J. Obstet. Gynaecol. 123, 1862–1870 (2016).
Kaul, A. et al. Systemic lupus erythematosus. Nat. Rev. Dis. Prim. 2, 1–21 (2016).
Elkon, Okay. B. Evaluate: Cell Loss of life, Nucleic Acids, and Immunity. Arthritis Rheumatol. 70, 805–816 (2018).
Heitzer, E., Auinger, L. & Speicher, M. R. Cell-Free DNA and Apoptosis: How Useless Cells Inform Concerning the Dwelling. Developments Mol. Med. 26, 519–528 (2020).
Jiang, P. & Lo, Y. M. D. The Lengthy and Wanting Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics. Developments Genet 32, 360–371 (2016).
Goggs, R., Jeffery, U., LeVine, D. N. & Li, R. H. L. Neutrophil-Extracellular Traps, Cell-Free DNA, and Immunothrombosis in Companion Animals: A Evaluate. Vet. Pathol. 57, 6–23 (2020).
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S. & Pretorius, P. J. The varied origins of circulating cell-free DNA within the human physique: a important re-evaluation of the literature. Biol. Rev. 93, 1649–1683 (2018).
Papayannopoulos, V. Neutrophil extracellular traps in immunity and illness. Nat. Rev. Immunol. 18, 134–147 (2018).
Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like illness. Nat. Med. 22, 146–153 (2016).
Chowdhury, C. S. et al. Elevated Ranges of Complete Cell-Free DNA in Maternal Serum Samples Come up from the Era of Neutrophil Extracellular Traps. Fetal Diagn. Ther. 40, 263–267 (2016).
Dinallo, V. et al. Neutrophil Extracellular Traps Maintain Inflammatory Alerts in Ulcerative Colitis. J. Crohns Colitis 13, 772–784 (2019).
Maronek, M. et al. Extracellular DNA Correlates with Intestinal Irritation in Chemically Induced Colitis in Mice. Cells 10, 81 (2021).
Wang, W.-M. & Jin, H.-Z. Position of Neutrophils in Psoriasis. J. Immunol. Res. 2020, 3709749 (2020).
Anani, H. A. A. et al. Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Sufferers. Psoriasis Targets Ther. 10, 13–21 (2020).
Xiao, F. et al. NETosis might play a job within the pathogenesis of Hashimoto’s thyroiditis. Int. J. Clin. Exp. Pathol. 11, 537–547 (2018).
Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl Acad. Sci. 107, 15880–15885 (2010).
Chan, R. W. Y. et al. Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing. Proc. Natl Acad. Sci. 111, E5302–E5311 (2014).
Malíčková, Okay. et al. Impaired Deoxyribonuclease I Exercise in Sufferers with Inflammatory Bowel Illnesses. Autoimmune Dis. 2011, 945861 (2011).
Leffler, J. et al. A subset of sufferers with systemic lupus erythematosus fails to degrade DNA from a number of clinically related sources. Arthritis Res. Ther. 17, 205 (2015).
Chan, R. W. Y. et al. Plasma DNA Profile Related to DNASE1L3 Gene Mutations: Scientific Observations, Relationships to Nuclease Substrate Choice, and In Vivo Correction. Am. J. Hum. Genet. 107, 882–894 (2020).
Lateef, A. & Petri, M. Managing lupus sufferers throughout being pregnant. Finest. Pract. Res. Clin. Rheumatol. 27, 435–447 (2013).
Knight, C. L. & Nelson-Piercy, C. Administration of systemic lupus erythematosus throughout being pregnant: challenges and options. Open Entry Rheumatol. Res. Rev. 9, 37–53 (2017).
Zhang, C., Liang, M., Xu, X., Zhang, X. & Chen, S. Scientific options of new-onset systemic lupus erythematosus in pregnant sufferers. J. Obstet. Gynaecol. Res. 44, 234–240 (2018).
Grömminger, S. et al. The affect of low molecular weight heparin treatment on plasma DNA in pregnant girls. Prenat. Diagn. 35, 1155–1157 (2015).
Ma, G.-C., Wu, W.-J., Lee, M.-H., Lin, Y.-S. & Chen, M. Low-molecular-weight heparin related to diminished fetal fraction and subsequent false-negative cell-free DNA take a look at outcome for trisomy 21. Ultrasound Obstet. Gynecol. 51, 276–277 (2018).
Torres, J. et al. Outcomes of the Seventh Scientific Workshop of ECCO: Precision Medication in IBD—Prediction and Prevention of Inflammatory Bowel Illness. J. Crohns Colitis 15, 1443–1454 (2021).
